, APAC
Chiew Pei Ru (Photo courtesy of Sompo International)

Sompo Int’l assigns new lead for crisis management, commercial P&C insurance

Chiew is based in Singapore and joins from AXA, where she was a senior underwriter.

Sompo International has named Pei Ru Chiew as lead for its Crisis Management team, Commercial P&C Insurance in Asia Pacific (APAC).

Chiew will be based in Singapore and reports to Paul O’Neill, President of Commercial Lines, Insurance, APAC.

Prior to joining Sompo International, Chiew was on AXA XL’s Singapore team as a senior underwriter of War, Terrorism and Political Violence. 

ALSO READ: Sompo International taps Alasdair Walker as regional head for distribution insurance

Before that, Chiew had also served as JLT Specialty as a Credit, Political and Security Risk broker and manager, and Marsh Asia as a Terrorism and Political Violence broker.

“As Sompo International continues to pursue its global objectives, a top priority includes deepening our relationships in APAC. We are seeing growing demand for political violence and terrorism insurance cover in this region. Pei Ru’s extensive experience in this sector well-positions her to work closely with our clients and broker partners delivering the solutions that meet their evolving needs,” O’Neill said.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.